Skip to content

Aptevo Therapeutics Inc.: filings

Every Aptevo Therapeutics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 41 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 202631890001193125-26-350559
10-Q2026-05-13fiscal Q1 202631650001193125-26-221661
10-K2026-03-26fiscal FY 202539770001193125-26-126278
10-Q2025-11-06fiscal Q3 202527840001193125-25-269598
10-Q2025-08-11fiscal Q2 202525750000950170-25-106247
10-Q2025-05-15fiscal Q1 202525530000950170-25-072622
10-K2025-02-14fiscal FY 202435690000950170-25-020467
10-Q2024-11-07fiscal Q3 202427800000950170-24-122837
10-Q2024-08-08fiscal Q2 202427770000950170-24-093366
10-Q2024-05-08fiscal Q1 202427540000950170-24-055096
10-K2024-03-05fiscal FY 202336690000950170-24-025428
10-Q2023-11-14fiscal Q3 202331860000950170-23-063379
10-Q2023-08-10fiscal Q2 202331820000950170-23-040983
10-Q2023-05-11fiscal Q1 202330590000950170-23-020870
10-K2023-03-30fiscal FY 202239770000950170-23-010757
10-Q2022-11-10fiscal Q3 202232920001564590-22-037287
10-Q2022-08-11fiscal Q2 202232880001564590-22-029025
10-Q2022-05-12fiscal Q1 202226520001564590-22-019685
10-K2022-03-24fiscal FY 202135680001564590-22-011575
10-Q2021-11-12fiscal Q3 202127740001564590-21-056494
10-Q2021-08-12fiscal Q2 202127710001564590-21-043955
10-Q2021-05-11fiscal Q1 202125500001564590-21-026319
10-K2021-03-31fiscal FY 202033640001564590-21-016875
10-Q2020-11-10fiscal Q3 202029690001564590-20-053058
10-Q2020-08-14fiscal Q2 202029690001564590-20-040295
10-Q2020-05-13fiscal Q1 202027530001564590-20-025066
10-K2020-03-25fiscal FY 201941770001564590-20-012791
10-Q2019-11-07fiscal Q3 201937910001564590-19-041524
10-Q2019-08-09fiscal Q2 201935850001564590-19-031118
10-Q2019-05-09fiscal Q1 201935690001564590-19-017616
10-K2019-03-18fiscal FY 201842800001564590-19-008184
10-Q2018-11-14fiscal Q3 201837950001564590-18-029562
10-Q2018-08-09fiscal Q2 201834880001564590-18-020781
10-Q2018-05-10fiscal Q1 201829590001564590-18-012733
10-K2018-03-13fiscal FY 201734700001564590-18-005384
10-Q2017-11-13fiscal Q3 201734950001564590-17-023382
10-Q2017-08-10fiscal Q2 201729760001564590-17-017132
10-Q2017-05-12fiscal Q1 201729590001564590-17-010737
10-K2017-03-31fiscal FY 2016351120001564590-17-005738
10-Q2016-11-14fiscal Q3 201629760001564590-16-029292
10-Q/A2016-09-22fiscal Q2 201633820000950123-16-020493

Inspect the source

Entity
Aptevo Therapeutics Inc. / CIK 0001671584
Captured
2026-09-21T17:24:21.399Z
SEC response SHA-256
79c4e035e65510fb4364121cfd545dab16c6a89232545f5c4f8a36a1cb035444

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001671584.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))